Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction: New Assessment of an Old Problem

Area of Science:

• Cardiology
• Clinical Medicine
• Translational Research

Background:

• Atrial fibrillation (AF) and heart failure (HF), particularly heart failure with reduced ejection fraction (HFrEF), frequently coexist.
• The interplay between AF and HFrEF is bidirectional, impacting mechanisms, clinical presentation, quality of life, and long-term outcomes.
• Shared risk factors for AF and HFrEF present opportunities for preventative strategies.

Purpose of the Study:

• To review the complex relationship between AF and HFrEF.
• To highlight updated multisociety guidelines for managing comorbid AF and HF.
• To provide context on clinical trial findings and evolving management recommendations.

Main Methods:

• Literature review focusing on the pathophysiology, risk factors, and clinical implications of coexisting AF and HFrEF.
• Analysis of recent clinical trial data relevant to this patient population.
• Synthesis of updated guideline recommendations.

Main Results:

• AF and HFrEF share overlapping risk factors and pathophysiological pathways.
• Management strategies are evolving, with updated guidelines incorporating specific recommendations for comorbid AF and HF.
• Clinical trials are providing new insights into effective interventions.

Conclusions:

• Effective management of patients with both AF and HFrEF requires a comprehensive approach addressing their intertwined nature.
• Understanding the shared mechanisms and risk factors is crucial for improving patient outcomes.
• Continued research and guideline updates are essential for optimizing care in this growing population.